Global Clinical Trials

Name

Global Clinical Trials

Legal name

Global Clinical Trials

Website

https://gctrials.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) / Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Trial Site Operations & Study Coordination (HLAGACAE), Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE)

Keywords

• Clinical trial management
• Contract research services
• Oncology clinical trials
• Regulatory affairs support
• Biotech CRO services

Headquarters

HQ city

Princeton

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Research Services: As a Contract Research Organization (CRO), Global Clinical Trials generates revenue by providing clinical trial management services including study design, site management, monitoring, data management, and regulatory support for pharmaceutical and biotech companies conducting clinical studies.

Go-to-market motion1 record

Distribution channels1 record

Core offering

Global Clinical Trials is a Contract Research Organization (CRO) that provides clinical trial management services to pharmaceutical and biotechnology companies. Its offerings include study design, site management, clinical monitoring, data management, and regulatory support, with specialized execution of international multi-site oncology trials such as the Phase 1b Sapu003 program for Sapu Nano.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Management Services
• Oncology Clinical Development Program Support
• International Multi-Site Clinical Trial Execution
• Regulatory Affairs and Compliance Support

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Sapu NanocoreImplementation/ SI/ Consulting Partner · 3 June 2026Global Clinical Trials was appointed as the lead CRO to support Sapu Nano's Phase 1b clinical development program for Sapu003. The partnership involves international trial execution including sites in Europe, evaluating safety, tolerability, and anti-tumor activity in patients with advanced mTOR-sensitive solid tumors. GCT provides comprehensive clinical trial management services for this oncology program.

Recent moves3 records

Expansion highlights4 records

Direct peers

• Worldwide Clinical Trials: Mid-sized global CRO offering Phase I-IV clinical trial services with deep therapeutic expertise across multiple areas including oncology. Closely comparable to GCT in size, service breadth, and target customer base of mid-biotech sponsors.
• Medpace: Public, mid-tier CRO known for full-service clinical development and strong oncology and specialty therapeutic capabilities. Highly comparable operating model serving biotech sponsors with complex, scientifically driven trials, though larger and more diversified than GCT.
• Ergomed (now part of Calyx): Specialty CRO historically focused on oncology and rare disease clinical trial services for small and mid-sized pharma sponsors. Highly comparable therapeutic focus and customer profile to GCT's disclosed oncology mTOR work.
• Premier Research: Specialty clinical CRO providing oncology, rare disease, and pediatric trial services primarily to small and mid-sized biotechs. Closely matches GCT in targeting under-served biotech sponsors with high-science, complex trials.
• Clinipace Worldwide: Mid-sized clinical CRO offering full-service trial management across oncology and other therapeutic areas for emerging biotechs. Comparable in size and go-to-market focus on scientifically complex, mid-biotech-sponsored studies.
• Rho (now part of Clario): Mid-sized US-based clinical CRO and consulting provider with strong oncology and infectious disease capabilities for biotech sponsors. Comparable in clinical operations scale, therapeutic mix, and biotech-focused customer base.

Emerging players

• Veristat: Smaller clinical CRO and biometrics provider supporting emerging biotech and rare disease sponsors with trial design, biostatistics, and clinical operations. Comparable in customer segment and oncology-heavy therapeutic mix, though narrower in scale than GCT.

Regional players

• Novotech: Asia-Pacific headquartered mid-sized CRO focused on oncology and other complex therapeutic areas for emerging biotech sponsors. Comparable in size and therapeutic emphasis, though geographically complementary rather than directly overlapping with GCT's US/European footprint.

Broad incumbents

• ICON plc: Global tier-1 CRO offering full-service clinical development and post-approval services across all major therapeutic areas. Competes with GCT for biotech sponsor awards, particularly on larger multi-region oncology programs.
• Syneos Health: Global tier-1 CRO offering clinical development and commercialization services across a broad therapeutic portfolio. Overlaps with GCT in oncology trial execution for mid-biotech sponsors and represents the upper bound of scale competition.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/gctrials
• Facebookfacebook.com/gctrials

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Global Clinical Trials